Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongli Yin

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Translational Medicine|February 11, 2026
NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastomaGen Li, Yanling Chen, Ran Zhuo, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 10, 2024
Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factorsYan Li, Zimu Zhang, Juanjuan Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 25, 2024
Super-Enhancer-Driven IRF2BP2 is Activated by Master Transcription Factors and Sustains T-ALL Cell Growth and SurvivalJuanjuan Yu, Zimu Zhang, Yanling Chen, et al.
Cancer Letters|April 18, 2024
CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastomaRan Zhuo, Zimu Zhang, Yanling Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 23, 2024
Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemiaTongting Ji, Yang Yang, Juanjuan Yu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
<i>USP20</i> as a super-enhancer-regulated gene drives T-ALL progression <i>via</i> HIF1A deubiquitinationLing Xu, Zimu Zhang, Juanjuan Yu, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Translational Medicine|February 11, 2026
NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastomaGen Li, Yanling Chen, Ran Zhuo, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 10, 2024
Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factorsYan Li, Zimu Zhang, Juanjuan Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 25, 2024
Super-Enhancer-Driven IRF2BP2 is Activated by Master Transcription Factors and Sustains T-ALL Cell Growth and SurvivalJuanjuan Yu, Zimu Zhang, Yanling Chen, et al.
Cancer Letters|April 18, 2024
CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastomaRan Zhuo, Zimu Zhang, Yanling Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 23, 2024
Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemiaTongting Ji, Yang Yang, Juanjuan Yu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
<i>USP20</i> as a super-enhancer-regulated gene drives T-ALL progression <i>via</i> HIF1A deubiquitinationLing Xu, Zimu Zhang, Juanjuan Yu, et al.
Pageof 6